期刊
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
卷 181, 期 1, 页码 21-28出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.resp.2011.12.008
关键词
Aquaporins; Asthma; Dexamethasone; Ambroxol; Terbutaline
资金
- National Natural Science Foundation of China [30871132, 30930090, 81100030]
- Science and Technology Commission of the Shanghai Municipality [08PJ1402900, 08DZ2293104, 09540702600]
- Distinguished Professor Grant for Fudan University and Zhongshan Hospital
- Shanghai Leading Academic Discipline Project [10206, B115]
Ovalbumin (OVA)-induced asthma in mouse lungs causes changes in the mRNA and protein levels of aquaporins (AQPs). AQP expression was examined in the presence of various anti-asthmatic agents, including dexamethasone, ambroxol, and terbutaline. The influence of these agents on OVA-induced airway inflammation was also evaluated. The mRNA expression levels of AQP1, 4, and 5 were significantly reduced and that of AQP3 was significantly increased 24h after the last OVA exposure. The protein levels of AQP1, 3, and 5 mirrored the mRNA expression profiles, but AQP4 did not exhibit any changes. Only the mRNA and protein expression levels of AQP1 and AQP5 were significantly increased by these three anti-asthmatic agents. Dexamethasone and ambroxol improved the eosinophil infiltration, mucus secretion, and pulmonary edema caused by OVA, but terbutaline only alleviated pulmonary edema. These results indicate that AQP1 and AQP5 are closely related to pulmonary edema but not to eosinophil infiltration or mucus secretion during asthma. Anti-asthmatic agents could alleviate pulmonary edema through upregulating the expression of AQP1 and AQP5 in mouse lungs that have OVA-induced asthma. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据